PMID: 9448882Aug 1, 1997Paper

Haemopoietic stem cell transplantation in Australia, 1992-95: a report from the Australian Bone Marrow Transplant Recipient Registry

Australian and New Zealand Journal of Medicine
K AtkinsonT Hawkins

Abstract

Bone marrow and blood stem cell transplantation is increasingly utilised in Australia. The Australian Bone Marrow Transplant Recipient Registry was founded in 1991 to record this activity. To describe allogeneic and autologous bone marrow and blood stem cell transplantation in Australia during 1992-95. Each bone marrow transplant programme in each State of Australia has been invited to contribute information to the Registry and all do. A single information sheet is compiled by the data manager in each programme when a marrow transplant is performed and mailed to the Registry office. An annual follow-up sheet is then mailed from the Registry to the contributing centre at the anniversary of each individual transplant. Australia-wide, haemopoietic cell transplants have increased in number from 478 in 1992 to 681 in 1995. The number of hospitals contributing registrations to the Australian Bone Marrow Transplant Registry has increased from 20 in 1992 to 25 in 1995. The main reason for the increased number of transplants is an increase in the number of autologous blood stem cell transplants including an increase in the number of staged autologous blood stem cell transplants. The most common indication for a single autologous transpl...Continue Reading

References

Jan 1, 1994·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·A Gratwohl
Oct 1, 1993·Australian and New Zealand Journal of Medicine·K AtkinsonD Staniforth
Dec 1, 1995·Australian Critical Care : Official Journal of the Confederation of Australian Critical Care Nurses·S Oliver

❮ Previous
Next ❯

Citations

Jul 18, 2001·Springer Seminars in Immunopathology·J Moore, P Brooks
Sep 21, 2000·Critical Reviews in Oncology/hematology·N SabaA Keating
Dec 10, 1999·Diabetic Medicine : a Journal of the British Diabetic Association·D SimmonsT Kenealy
Feb 23, 1999·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·P R EbelingA P Grigg
Jul 17, 2010·Journal of Gastroenterology·Golo AhlenstielJacob George
Jul 3, 2009·World Journal of Surgery·Guiseppe GarceaGuy J Maddern
Aug 4, 2009·Journal of Vascular and Interventional Radiology : JVIR·Boris NikolicJohn F Cardella
Jan 22, 2005·Neurologic Clinics·Harold Atkins, Mark Freedman
Mar 12, 2015·Progress in Transplantation : Official Publication, North American Transplant Coordinators Organization ... [et Al.]·Lyn PhillipsonMiriam Nonu
May 27, 2015·Internal Medicine Journal·M B StokesD McGiffin
Jan 26, 2007·Suicide & Life-threatening Behavior·Marc S Daigle, Gilles Côté
Feb 25, 2003·Cancer Control : Journal of the Moffitt Cancer Center·Jacob M Van Laar, Alan Tyndall

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.